Hunan Nucien Pharmaceutical Co., Ltd. (SHA:688189)
7.99
-0.16 (-1.96%)
Mar 9, 2026, 4:00 PM EDT
SHA:688189 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 490.27 | 665.76 | 713.47 | 730.67 |
Cash & Short-Term Investments | 427.81 | 490.27 | 665.76 | 713.47 | 730.67 |
Cash Growth | -12.74% | -26.36% | -6.69% | -2.35% | -24.04% |
Accounts Receivable | - | 199.9 | 563.74 | 741.49 | 590.81 |
Other Receivables | - | 5.78 | 0.95 | 6.36 | 207.56 |
Receivables | - | 205.68 | 564.69 | 747.85 | 798.37 |
Inventory | - | 61.17 | 30.37 | 27.01 | 61.43 |
Prepaid Expenses | - | 1.62 | 3.52 | 0.32 | 3.65 |
Other Current Assets | - | 19.61 | 7.52 | 7.51 | 19.06 |
Total Current Assets | - | 778.35 | 1,272 | 1,496 | 1,613 |
Property, Plant & Equipment | - | 164.3 | 186.29 | 204.62 | 229.74 |
Goodwill | - | - | 10.85 | 10.85 | 13.57 |
Other Intangible Assets | - | 143.13 | 124.28 | 138.01 | 158.41 |
Long-Term Deferred Tax Assets | - | 51.17 | 57.26 | 54.82 | 72.22 |
Long-Term Deferred Charges | - | 77.5 | 64.19 | 46.23 | 40.48 |
Other Long-Term Assets | - | 7.99 | 4.65 | 3.91 | 3.27 |
Total Assets | - | 1,222 | 1,719 | 1,955 | 2,131 |
Accounts Payable | - | 39.59 | 39.55 | 37.5 | 156.47 |
Accrued Expenses | - | 53.39 | 31.97 | 39.26 | 56.34 |
Short-Term Debt | - | 218.19 | 322.95 | 488.73 | 385.44 |
Current Portion of Long-Term Debt | - | - | - | 50.85 | 33.9 |
Current Portion of Leases | - | 0.71 | 0.71 | 0.68 | 1.13 |
Current Income Taxes Payable | - | 0.57 | 1.2 | 2 | - |
Current Unearned Revenue | - | 1.72 | 13.48 | 13.3 | 27.21 |
Other Current Liabilities | - | 25.69 | 18.17 | 16.04 | 14.2 |
Total Current Liabilities | - | 339.85 | 428.04 | 648.36 | 674.67 |
Long-Term Debt | - | - | - | - | 50.85 |
Long-Term Leases | - | 0.23 | 0.94 | 3.39 | 4.07 |
Long-Term Unearned Revenue | - | 3 | 3.3 | 4.2 | 5.62 |
Long-Term Deferred Tax Liabilities | - | 1.05 | 1.53 | 2.29 | 1.68 |
Total Liabilities | - | 344.13 | 433.8 | 658.24 | 736.89 |
Common Stock | - | 274.4 | 274.4 | 196 | 140 |
Additional Paid-In Capital | - | 1,175 | 1,175 | 1,254 | 1,310 |
Retained Earnings | - | -503.22 | -146.32 | -135.45 | -56.62 |
Treasury Stock | - | -10 | - | - | - |
Total Common Equity | 865.99 | 936.59 | 1,303 | 1,314 | 1,393 |
Minority Interest | - | -58.29 | -17.92 | -17.99 | 0.79 |
Shareholders' Equity | 800.56 | 878.31 | 1,286 | 1,296 | 1,394 |
Total Liabilities & Equity | - | 1,222 | 1,719 | 1,955 | 2,131 |
Total Debt | 148.2 | 219.12 | 324.6 | 543.65 | 475.38 |
Net Cash (Debt) | 279.61 | 271.15 | 341.16 | 169.82 | 255.29 |
Net Cash Growth | 3.12% | -20.52% | 100.89% | -33.48% | -58.59% |
Net Cash Per Share | 1.02 | 0.99 | 1.24 | 0.62 | 0.93 |
Filing Date Shares Outstanding | 273.39 | 272.83 | 274.4 | 274.4 | 274.4 |
Total Common Shares Outstanding | 273.39 | 272.83 | 274.4 | 274.4 | 274.4 |
Working Capital | - | 438.5 | 843.82 | 847.82 | 938.51 |
Book Value Per Share | 3.18 | 3.43 | 4.75 | 4.79 | 5.08 |
Tangible Book Value | 735.1 | 793.46 | 1,168 | 1,166 | 1,221 |
Tangible Book Value Per Share | 2.70 | 2.91 | 4.26 | 4.25 | 4.45 |
Buildings | - | 220.56 | 220.56 | 220.27 | 220.27 |
Machinery | - | 229.88 | 270.67 | 264.88 | 262.76 |
Construction In Progress | - | 0.35 | 0.57 | 0.24 | 1.28 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.